Yet Another Reminder of the Value of Lung Cancer Screening

In the past decade, several clinical trials have revealed the efficacy of lung cancer screening with low-dose computed tomography (CT) imaging in reducing mortality from lung cancer.1–3 These studies illustrate the value of CT lung screening (CTLS) in reducing cancer mortality and overall mortality in high-risk individuals. Patients with previous cancers were excluded from these trials. Although “LDCT” was initially the term used for lung...